The largest database of trusted experimental protocols

3 protocols using rottlerin

1

Integrin-mediated Signaling Pathway Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
All reagents unless otherwise specified were from Sigma-Aldrich. Wortmannin, Ly294002, rottlerin, bisindolylmaleimide i, bisindolylmaleimide ix, Gö6983 were from Cayman Chemical. P11, GRGDSP, GRADSP, αvβ3 function blocking antibody (LM609) were from EMD Millipore. PP1, PP2, PP3 were from Calbiochem. LDH assay was from Promega. Phospho-MARCKS Ser152/156 (Cat#2741), MARCKS (Cat#5607), Phospho-PI3K (Cat#4228), p85 PI3K (Cat#4257), Phospho-PKCδ (Cat#2055), PKCd (Cat#9616) antibodies were from Cell Signaling Technology. FITC-PIP3 antibody (Cat#G345) was from Echelon. All secondary antibodies and isotype controls were from Life Technologies.
+ Open protocol
+ Expand
2

Neutrophil Inhibitor Evaluation for Candida

Check if the same lab product or an alternative is used in the 5 most similar protocols
Neutrophils were pre-treated with indicated inhibitors 30 min before addition of C. albicans. Inhibitors SkyI (for Syk), BAPTA-AM (a selective chelator of Ca2+), Ro 318220 (for total PKC), Rottlerin (for PKCδ), BB-CI-Amidine (for PAD1-4), GSK484 (for PAD4) were all purchased from Cayman. Ro 6976 (for PKCα+β1), LY 333531 (for PKCβ) were from Millipore.
+ Open protocol
+ Expand
3

Intestinal Barrier Regulation by PKC Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Caco-2 cells seeded on Millicells and mounted in Ussing chambers were treated apically with inhibitors for 30-60 min prior to the apical challenge of RGal (1000 μg ml À1 ). The pan PKC inhibitor, GF109203X (500 nM, Tocris), the myristoylated PKCζ pseudosubstrate inhibitor (10 μM, Enzo Life Sciences, Farmingdale, NY, USA), the PKCα/β inhibitor, Go6976 (10 nM, Tocris), the PKCδ inhibitor, Rottlerin (3 μM, Cayman Chemical), the MEK1/2 inhibitor, U0126 (20 μM, Cayman Chemical), and the p38 inhibitor SB203580 (20 μM, Cayman Chemical) were added 30 min before RGal addition. The TLR4 inhibitor C34 (100 μg ml À1 ) was added apically 1 h before mounting in Ussing chambers.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!